March 17, 2015
Minophagen Pharmaceutical said on March 16 that it has filed a new drug application in Japan for bexarotene, a cutaneous T-cell lymphoma (CTCL) agent licensed from Eisai. The agent hit the US market in 1999 under the trade name of...read more